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Abstract: Background: Cataract is a leading cause of vision impairment worldwide, and surgery
is the only available treatment. The process that initiates lens opacification is dependent on the
oxidative stress experienced by the lens components. A healthy overall dietary pattern, with the
potential to reduce oxidative stress, has been suggested as a means to decrease the risk of developing
cataract. We aimed to investigate the hypothesis that an intervention with a Mediterranean diet
(MedDiet) rather than a low-fat diet could decrease the incidence of cataract surgery in elderly subjects.
Methods: We included 5802 men and women (age range: 55–80 years) from the Prevención con
Dieta Mediterránea study (multicenter, parallel-group, randomized controlled clinical trial) who had
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not undergone cataract surgery. They were randomly assigned to one of three intervention groups:
(1) a MedDiet enriched with extra-virgin olive oil (EVOO) (n = 1998); (2) a MedDiet enriched with
nuts (n = 1914), and a control group recommended to follow a low-fat diet (n = 1890). The incidence
of cataract surgery was recorded yearly during follow-up clinical evaluations. Primary analyses
were performed on an intention-to-treat basis. Cox regression analyses were used to assess the
relationship between the nutritional intervention and the incidence of cataract surgery. Results:
During a follow-up period of 7.0 years (mean follow-up period: 5.7 years; median: 5.9 years),
559 subjects underwent cataract surgery. Two hundred and six participants from the MedDiet + EVOO
group, 174 from the MedDiet + Nuts group, and 179 from the control group underwent cataract
surgery. We did not observe a reduction in the incidence of cataract surgery in the MedDiet groups
compared to the control group. The multivariable adjusted hazard ratios were 1.03 (95% confidence
interval [CI]: 0.84–1.26, p = 0.79) for the control group versus the MedDiet + EVOO group and
1.06 (95% CI: 0.86–1.31, p = 0.58) for the control group versus the MedDiet + Nuts group. Conclusions:
To our knowledge, this is the first large randomized trial assessing the role of a MedDiet on the
incidence of cataract surgery. Our results showed that the incidence of cataract surgery was similar in
the MedDiet with EVOO, MedDiet with nuts, and low-fat diet groups. Further studies are necessary
to investigate whether a MedDiet could have a preventive role in cataract surgery.
Keywords: Mediterranean diet; PREDIMED; cataract; cataract surgery; nuts; extra-virgin olive oil;
low-fat diet; antioxidants
1. Introduction
The prevalence of cataract is high among elderly individuals, and it is the primary cause of
blindness worldwide [1]. The number of people with age-related cataract has been predicted to
increase dramatically in the next 20 years worldwide, especially in Western countries, because of the
increasing life expectancy [2]. The only available treatment to restore vision after cataract formation
is via intraocular surgery, and this imposes a major medical cost and heavy workload burden on the
health care systems [3].
Oxidative stress is believed to be involved in the formation and maturation of cataract, causing
damage to the proteins and lipids of the lens epithelium [4–6]. Age, ultraviolet light exposure,
smoking, and corticosteroid use are recognized risk factors associated with cataract formation [7,8].
Besides other risk factors such as abdominal obesity [9] and hormonal therapy [10], the production
of proinflammatory components increases the levels of free oxygen radicals [11,12], which have been
associated with an increasing risk of cataract.
A significant and growing body of observational research suggests that an appropriate nutritional
intervention may offer a way to decrease the risk of cataract [13]. Accordingly, the association
between cataract progression and nutritional exposure is a matter of great scientific interest. Recently,
an inverse association between the total antioxidant capacity (TAC) and the risk of age-related
cataract has been reported [8]. In some trials, free oxygen radicals have been identified as one
of the most important causes of cataract formation [10]. A fair number of cohort studies have
focused on assessing the association between the intake of several specific nutrients in the diet
and cataract formation [11–19]. In some of those studies, an antioxidant-rich diet was reported to
potentially delay cataract progression [20]; other studies have reported that healthier diets could
prevent cataract formation [21–25]. Some nutritional supplements, including different antioxidants [26],
lutein/zeaxanthin [27–30] and omega-3 [31] and omega-6 [32] fatty acids, have been suggested to
reduce cataract progression.
The Mediterranean diet (MedDiet) is recognized as one of the healthiest dietary patterns and
has proven beneficial for several health outcomes [33,34]. However, no randomized trial to date has
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assessed the long-term effect of a MedDiet on the risk of cataract development in a large population of
elderly subjects. We hypothesized that two MedDiets, one enriched with extra-virgin olive oil (EVOO)
and another with mixed nuts, rather than a low-fat control diet could decrease the incidence of cataract
surgery in a population at a high risk of cardiovascular disease (CVD) enrolled to the Prevención con
Dieta Mediterránea (PREDIMED) trial.
2. Methods
2.1. PREDIMED Trial
The analysis was conducted within the framework of the PREDIMED study (www.predimed.es) [35],
a parallel-group, randomized, primary CVD prevention trial in persons at high risk of CVD. The main
results of the trial related to the primary cardiovascular endpoint have been published elsewhere [36].
The study was conducted in accordance with the Declaration of Helsinki. The Institutional Review
Board of the respective recruitment centers approved the study protocol and all participants gave their
informed consent. Trial Registration: clinicaltrials.gov Identifier: ISRCTN35739639.
2.2. Participants
Participants were men (age range: 55–80 years) or women (age range: 60–80 years) initially
free of CVD. The inclusion criteria were the presence of either type 2 diabetes or ≥3 major
cardiovascular risk factors, including current smoking (>1 cigarette/day during the last month),
hypertension (systolic BP ≥140 mmHg or diastolic BP ≥90 mmHg or under antihypertensive
medication), LDL cholesterol ≥160 mg/dL or receiving lipid-lowering therapy, HDL cholesterol
≤40 mg/dL in men or≤50 mg/dL in women, body mass index (BMI)≥25 kg/m2, and a family history
of premature coronary heart disease [35].
The exclusion criteria were a previous history of CVD (i.e., a previous medical diagnosis
of acute myocardial infarction, stroke, or peripheral arterial disease), any severe chronic illness,
immunodeficiency or human immunodeficiency virus positivity, illegal drug or alcohol abuse, history
of allergy to olive oil or nuts, and low predicted likelihood of changing dietary habits according to the
Prochaska and DiClemente stages of change model [35].
In total, 7447 participants were enrolled in the PREDIMED study. The selection process started
by extracting the names of potential participants from the records of around 200 primary care
centers (PCCs) affiliated with 11 Spanish teaching hospitals between October 2003 and January 2009.
The clinical records of these participants were then individually reviewed to exclude those who did not
meet the eligibility criteria. Potential participants were approached by the PCCs via a telephone call or
during their clinical visits. If the candidates were interested in participating, a face-to-face interview
was scheduled. During this interview, the purpose and characteristics of the study were explained,
and signed informed consent was obtained from willing participants. A brief explanation of the study,
including the possibility that they might receive free allowances of EVOO or nuts for the duration of
the trial, was given at this first visit [35].
2.3. Randomization and Intervention
Once entered into the study, the participants were randomly assigned in a 1:1:1 ratio to one of
the following three intervention groups: (1) MedDiet supplemented with EVOO (MedDiet + EVOO);
(2) MedDiet supplemented with mixed nuts (MedDiet + Nuts); or (3) a control diet (a low-fat diet
according to the American Heart Association guidelines applicable as of 2002). The two groups
allocated the MedDiets received intensive education to follow the MedDiet and supplemental
foods at no cost. EVOO (1 L/week for the participant and his/her family) was provided to the
MedDiet + EVOO group, and mixed nuts (30 g/day; 15 g walnuts, 7.5 g hazelnuts, and 7.5 g almonds)
were provided to the MedDiet + Nuts group. The participants in the control group did not receive
education on the MedDiet, but were adviced to follow a low-fat diet [35].
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Randomization was performed centrally by means of a computer-generated random-number
sequence. Investigators and members of all committees were blinded to the treatments assigned to
individual participants. In the present analysis, our main objective was to determine the effect of the
three dietary interventions on the incidence of cataract surgery.
2.4. Follow-Up and Adherence
At baseline and during the yearly follow-up visits, all participants underwent clinical evaluations
with their general practitioners. In addition they completed a 14-item questionnaire to assess
adherence to the MedDiet; a 77-item general questionnaire about lifestyle variables, educational
achievement, history of illnesses (including cataract surgery), and medication use; a 137-item validated
food-frequency questionnaire [36]; and a validated Spanish version of the Minnesota Leisure-Time
Physical Activity Questionnaire.
Biomarkers of adherence to the MedDiet interventions were measured in a random sample of
PREDIMED participants during the first 5 years of follow-up, and included urine hydroxytyrosol
concentrations and plasma α-linolenic acid proportions, which are reliable biomarkers of EVOO and
walnut intake, respectively [36]. General practicioners and laboratory technicians were blinded to the
participants’ intervention groups.
2.5. Outcome Measures
The outcome we investigated was the occurrence of cataract surgery at any time throughout the
study period. Cataract surgery (externally confirmed by an independent Adjudication Committee
blinded to the intervention and to the dietary habits of the participants) was a prespecified secondary
outcome of the PREDIMED trial. Patients with cataract surgery in any eye present at baseline were
excluded from the analyses. For the assessment of incident cataract surgery during the follow-up
period, the participants visited their general practitioners yearly for clinical evaluations and completed
several questionnaires, including a general medical questionnaire recording changes in the health
status and, specifically, if they had undergone cataract surgery. The cataract surgery outcome was
defined by the medical diagnosis made by an ophthalmologist, and was explicitly reported in the
medical charts. The occurrence of cataract surgery was also confirmed by periodically reviewing the
computer-based records of the corresponding PCCs. These reports and all relevant documentation,
including medical records made by the ophthalmologist, were sent to the PREDIMED members of the
Clinical Adjudication Event Committee, who were blinded to the interventions. As cataract extraction
was a predefined secondary endpoint in the trial, the Adjudication Committee reviewed the medical
charts comprehensively for potential cataract extraction, and only definitively confirmed cases were
included in this analysis. Cases of traumatic cataracts and cases that appeared after another intraocular
surgery, such as vitrectomy or glaucoma surgery, were also excluded. In cases of bilateral surgery in the
same patient, only the first event was considered in our time-to-event analyses. Our analyses focused
on a subset of 5802 participants from the PREDIMED trial who had not undergone cataract surgery at
baseline: 1998, 1914, and 1890 participants were allocated to the MedDiet + EVOO, MedDiet + Nuts,
and control diet groups, respectively. The remaining 1645 participants enrolled in the PREDIMED
study were excluded because they had undergone cataract surgery before the beginning of the trial.
2.6. Statistical Analysis
Baseline differences between the three dietary intervention groups were tested using analysis of
variance or chi-squared tests, and results were expressed as means ± SD or numbers (percentages),
respectively. The normality of variables was examined by using the Kolmogorov-Smirnov test.
All analyses were performed on the basis of an intention-to-treat principle.
Person-time of follow-up was calculated as the interval between the randomization date and the
earliest date of the follow-up contact at which a new cataract surgery was recorded, or the last visit or
death, whichever came first.
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We used unadjusted, age- and sex-adjusted, and multivariable time-dependent Cox proportional
hazard models to assess the effect of the two MedDiet interventions on the incidence of cataract surgery
in comparison with the control group. Hazard ratios (HRs) and 95% confidence intervals (CIs) were
calculated using the control group as the reference. In multivariable models, we adjusted the estimates
for the following confounders: age, sex, baseline type 2 diabetes, baseline hypertension, baseline
BMI (4 categories), and smoking status (3 categories). All models were stratified by recruitment
center. Prespecified interactions with sex, age, or baseline type 2 diabetes were tested using the
likelihood ratio test in fully adjusted models. A fully adjusted multivariable analysis was repeated
after both the MedDiet groups were merged into a single category for comparison with the control
group. The assumption of proportional hazards was tested by analyzing the scaled Schoenfeld
residuals, and it was not violated (p > 0.50). The test for time-varying covariates also suggested that the
assumption of proportional hazards was met. We also used the Kaplan-Meier method to graphically
estimate the cumulative incidence of cataract surgeries. A 2-tailed p value < 0.05 was considered
statistically significant. In addition, we performed prespecified subgroup analysis within the strata
of age, sex, and BMI. Analyses were performed using IBM SPSS Statistics for Windows Version 19.0
(IBM Corp., Armonk, NY, USA) and Stata 12.0 (StataCorp, College Station, TX, USA).
3. Results
The overall baseline characteristics and intake of energy and nutrients as well as the consumption
of key foods by the study participants in the dietary intervention groups are listed in Tables 1 and 2,
respectively. The mean age of the participants was 66 years and their mean BMI was 30.1 kg/m2; 45%
of them were men. The participants in all three intervention groups were well matched for age, sex,
anthropometric features, and other cardiovascular risk factors (data not shown).
Table 1. Baseline Characteristics of the PREDIMED Trial Participants by Intervention Group.
Characteristic
Mediterranean Diet
with EVOO
Mediterranean Diet
with Nuts Control Diet
N = 1998 N = 1914 N = 1890
Age—year (mean ± SD) 66.1 ± 6.1 65.8 ± 5.9 66.3 ± 6.2
Sex (female)—No. (%) 1120 (56.1) 985 (51.5) 1099 (58.2)
Smoking—No. (%)
Never smoker 1189 (59.5) 1117 (58.4) 1147 (60.7)
Former smoker 510 (25.5) 497 (26.0) 449 (23.8)
Current smoker 299 (15.0) 300 (15.7) 294 (15.6)
Body mass index † (mean ± SD) 30.0 ± 3.7 30.0 ± 3.8 30.3 ± 4.1
Waist to height ratio (mean ± SD) 0.63 ± 0.06 0.62 ± 0.06 0.63 ± 0.07
Waist circumference (mean ± SD) 100 ± 10 100 ± 11 101 ± 11
Hypertension ‡—No. (%) 1634 (81.8) 1591 (83.1) 1577 (83.4)
Type-2 diabetes §—No. (%) 970 (48.6) 851 (44.5) 897 (47.5)
Dyslipidemia ¶—No. (%) 1440 (72.1) 1414 (73.9) 1369 (72.4)
Family history of premature CHD—No. (%) | 447 (22.4) 426 (22.3) 442 (23.4)
Physical activity—METS-min/day (mean ± SD) 232 ± 229 248 ± 249 213 ± 236
Plus–minus values are means ± SDs. † The body-mass index (BMI) is the weight in kilograms divided by the square
of the height in meters. ‡ Hypertension was defined as systolic blood pressure≥140 mm Hg, diastolic blood pressure
≥90 mm Hg, or use of antihypertensive therapy. § Diabetes was defined as fasting blood glucose ≥126 mg/dL
(7.0 mmol/L) on two occasions, or 2-h plasma glucose ≥200 mg/dL (11.1 mmol/L) after a 75-g oral glucose load,
or use of antidiabetic medication. ¶ Dyslipidemia was defined as low-density lipoprotein cholesterol >160 mg/dL,
high-density lipoprotein cholesterol ≤40 mg/dL in men or ≤50 mg/dL in women, or use of lipid-lowering therapy.
| A family history of premature coronary heart disease (CHD) was defined as diagnosis of the disease in a male
first-degree relative before the age of 55 years or in a female first-degree relative before the age of 65 years.
Nutrients 2017, 9, 453 6 of 12
Table 2. Baseline intake of Energy, Nutrients and Key Foods of the PREDIMED Trial Participants by
Intervention Group.
Variable
Mediterranean Diet
with EVOO
Mediterranean Diet
with Nuts Control Diet
N = 1998 N = 1914 N = 1890
Total energy intake (kcal/day) (mean ± SD) 2288 ± 612 2329 ± 620 2222 ± 602
Carbohydrate (g/day) (mean ± SD) 238.8 ± 81.7 242.6 ± 83.4 234.3 ± 79.2
Fiber (g/day) (mean ± SD) 25.4 ± 9.1 25.9 ± 9.2 24.7 ± 8.6
Protein (g/day) (mean ± SD) 93.3 ± 24.3 94.4 ± 23.2 90.4 ± 22.3
Fat (g/day) (mean ± SD) 99.5 ± 30.5 101.3 ± 30.2 96.3 ± 31.0
Saturated fatty acids 25.4 ± 9.1 25.8 ± 9.1 24.8 ± 9.3
Monounsaturated fatty acids 49.6 ± 16.0 50.0 ± 15.6 47.7 ± 16.5
ω-6 Polyunsaturated fatty acids 13.0 ± 6.4 13.7 ± 6.6 12.8 ± 6.2
ω-3 Marine PUFA 1.39 ± 0.75 1.51 ± 0.79 1.32 ± 0.65
Cholesterol (mg/day) (mean ± SD) 369.1 ± 137.5 374.3 ± 130.4 362.1 ± 128.5
Cereals (g/day) (mean ± SD) 231.4±114.1 234.6 ± 108.6 225.6 ± 106.0
Vegetables (g/day) (mean ± SD) 344.5 ± 159.6 339.4±152.1 324.8±143.9
Fruits (g/day) (mean ± SD) 369.4 ± 212.5 370.2 ± 203.1 357.1 ± 200.6
Total nuts (g/day) (mean ± SD) 9.6 ± 13.9 12.5 ± 15.2 8.9 ± 12.6
Dairy Products (g/day) (mean ± SD) 378.8 ± 214.0 374.0 ± 220.6 376.0 ± 226.0
Red Meat (g/day) (mean ± SD) 134.7 ± 63.2 137.4 ± 59.8 130.0 ± 55.8
Seafood (g/day) (mean ± SD) 103.5 ± 54.7 102.4 ± 53.4 98.4 ± 48.2
Olive Oil (g/day) (mean ± SD) 40.5 ±1 7.9 39.8 ± 17.4 38.4 ± 18.6
Alcohol consumption (g/day) (mean 9.1 ± 14.9 9.8 ± 15.5 7.9 ± 13.5
MedDiet Adherence score ‖ (mean ± SD) 8.7 ± 2.0 8.8 ± 2.0 8.4 ± 2.1
Mediterranean diet (MedDiet) adherence score (minimum adherence = 0 points; maximum adherence = 14 points).
EVOO denotes extra virgin olive oil.
During the follow-up period, 559 of the 5802 participants (9.6%) from the three intervention
groups underwent cataract surgery, including 206 (10.3%) from the MedDiet + EVOO group, 174 (9.1%)
from the MedDiet + Nuts group, and 179 (9.4%) from the control group. It must be noted that the
number of participants who underwent cataract surgery does not correspond with the total number
of eyes that underwent surgeries because we considered only the number of participants operated,
regardless of whether they underwent surgery in one or both eyes.
We did not observe a reduction in the incidence of cataract surgery in the groups assigned
to the MedDiet versus the control group. The observed rates (per 1000 person-years) were 16.9,
17.6, and 16.2 for the MedDiet + EVOO, MedDiet + Nuts, and control groups, respectively (Table 3).
Figure 1 displays the incidence of cataract surgery and the HRs and their 95% CIs for the effect of
the two MedDiet interventions in comparison with the control group. Compared with the control
group, the MedDiet + EVOO group had an unadjusted HR for the incidence of cataract surgery of
1.02 (95% CI, 0.84–1.25) and the MedDiet + Nuts group had a value of 0.97 (95% CI, 0.78–1.19). When
we adjusted for some possible confounders (age, sex, baseline type 2 diabetes, baseline hypertension,
baseline BMI, and smoking status), we did not observe a significant difference between the MedDiet
groups and the control group, with multivariable-adjusted HR of 1.03 (95% CI, 0.84–1.26) for the
MedDiet + EVOO group and 1.06 (95% CI, 0.86–1.31) for the MedDiet + Nuts group. Moreover,
no significant difference was observed in the incidence of cataract surgery between the control group
and both the MedDiet groups, when combined. In addition, we did not find any meaningful difference
between the control group and the MedDiet groups when we analyzed for different subgroups of age,
sex, and BMI (Table 4).
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Figure 1. Incidence of cataract surgery during follow-up among the 3 interventions group.
Table 3. Hazard ratios (95% CI) for the risk of cataract, according to the intervention group.
Control Diet Mediterranean Diet with EVOO Mediterranean Diet with Nuts
(n = 1890) (n = 1998) (n = 1914)
Cases/Person-years 179/10,633 206/11,728 174/10,719
Rate (/1000 person-years) 16.9 17.6 6.2
Crude rate ratio 1 (ref) 1.02 (0.84 to 1.25) 0.97 (0.78 to 1.19)
Multivariable adjusted rate ratio * 1 (ref) 1.03 (0.84 to 1.26) 1.06 (0.86 to 1.31)
Results obtained from Cox regression models. * adjusted for age, sex, baseline type 2 diabetes, baseline hypertension,
baseline body mass index (4 categories) and smoking status (3 categories) and stratified by recruitment center.
Note: interactions with sex, age or baseline type 2 diabetes were not statistically significant.
Ta le 4. Subgroup azard ratios (95 CI) for the risk of cataract, a cording to the intervention group.
Control Diet Mediterranean Diet with EVOO Mediterranean Diet with Nuts
(n = 1890) (n = 1998) (n = 1914)
Age
Participants aged <60 years
Cases/Person-years 5/1375 14/1420 6/1559
Multivariable adjusted rate ratio * 1 (ref.) 2.53 (0.88–7.24) 1.21 (0.35–4.20)
Participants aged 60 ≤70 years
Cases/Pe son-years 85/6055 103/6806 94/6430
Multivariabl adjust d rate ratio * 1 (ref.) 1.05 (0.78–1.40) 1.07 (0.80–1.44)
Participants aged ≥70 years
Cases/Pe son-years 89/3204 89/35 2 74/2730
Multivariable adjusted rate ratio * 1 (ref.) 0.90 (0.67–1.22) 1.01 (0.74–1.38)
Sex
Men
Cases/Person-years 59/4451 86/5137 67/5300
Multivariable adjusted rate ratio ** 1 (ref.) 1.22 (0.87–1.70) 1.00 (0.70–1.43)
Women
Cases/Pe son-years 120/6183 120/659 07/5419
Multivariable adjusted rate ratio ** 1 (ref.) 0.92 (0.71–1.19) 1.12 (0.86–1.45)
Body mass index
<30 kg/m2
Cases/Person-years 81/5412 111/6197 93/5932
Multivariable adjusted rate ratio *** 1 (ref.) 1.23 (0.92–1.64) 1.14 (0.84–1.54)
≥30 kg/m2
Cases/Person-years 98/5222 95/5530 81/4786
Multivariable adjusted rate ratio *** 1 (ref.) 0.86 (0.65–1.15) 0.97 (0.72–1.31)
Results obtained from Cox regression models. * adjusted for age, sex, baseline type 2 diabetes, baseline hypertension,
baseline body mass index (4 categories) and smoking status (3 categories) and stratified by recruitment center.
** adjusted for age, baseline type 2 diabetes, baseline hypertension, baseline body mass index (4 categories) and
smoking tatus (3 categories) and stratified by recruitment center. *** adjusted for age, sex, baseline type 2 diabetes,
baseline hypertension, and smoking status (3 categories) and stratified by recruitment center.
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4. Discussion
Our analysis in the setting of the PREDIMED trial, including a middle-aged and elderly population
with three or more CVD risk factors, was not able to confirm the initial hypothesis, because after
7.0 years of follow-up, we did not observe any significant differences in the incidence of cataract surgery
between the participants assigned to the two MedDiet groups and the control group. The results
showed that for both the MedDiet groups, the HRs for the incidence of cataract surgery were near
the reference (null) value of 1.0. The results also remained non-significant after adjusting for certain
potential confounders and analyzing the different subgroups according to age, sex, and BMI. Our
findings are in accordance with those of good-quality trials, such as the Age-Related Eye Disease Study,
and prospective epidemiological studies [37] that did not provide support for a beneficial effect of
antioxidants in reducing the risk of cataract formation or extraction. However, we acknowledge that
other studies did show a significant reduction in cataract incidence or progression associated with the
intake of antioxidants [13–19].
The primary aim of the PREDIMED trial was to assess the role of a MedDiet in the primary
prevention of cardiovascular events [36].The main focus of the intervention was to change the overall
dietary pattern, adding to a healthy diet the extra benefit of monounsaturated and polyunsaturated
fatty acids and other nutrients provided by EVOO and nut supplements, instead of focusing on
changes in single macronutrients or micronutrients. In contrast with the null effect on cataract surgery,
both the MedDiets supplemented with EVOO or nuts were beneficial in reducing the risk of major
cardiovascular events [36], when compared to a low-fat diet, thereby demonstrating the protective
effects of the MedDiet including EVOO and nuts.
To our knowledge, this study is the first large randomized trial to assess the effects of a MedDiet on
the incidence of cataract. Numerous studies have investigated the association between diet and cataract
and have focused on the effects of single micronutrients with antioxidant properties (e.g., vitamins A, B,
C, and E; lutein/zeaxanthin; beta-carotene; or selenium). Although several of them have demonstrated
an inverse relationship between these micronutrients and the development of age-related cataract
or the incidence of cataract surgery, others have reported inconsistent results [38,39], showing no
consensus about their importance. Instead, other studies have focused on the TAC [8], taking into
account the capacity of all antioxidants in the diet and their synergic effect, demonstrating that dietary
TAC was inversely associated with the risk of age-related cataract. Other trials have focused on
the effects of single macronutrients such as lipids, and several have reported an inverse association
between the intake of polyunsaturated fatty acids, like omega-3 and omega-6 fatty acids, and the risk
of cataract [31]. The MedDiet is considered one of the healthiest dietary patterns and contains all the
individual micronutrients that have an antioxidant effect. In our study, we tested the combined benefits
of a MedDiet as well as EVOO and nuts that contain significant amounts of omega-3 fatty acids and
bioactive compounds (including fiber, minerals, tocopherols, phytosterols, and phenolic compounds)
with strong antioxidant effects. However, despite combining the effects of single antioxidants and the
benefits provided by EVOO and nuts, the MedDiet used in our study did not show any superiority in
reducing the incidence of cataract surgery when compared to a low-fat diet. Lu et al. [40] observed
that saturated and polyunsaturated fats were not associated with the risk of cataract extraction, even
though total fat intake was marginally associated with an increased risk of cataracts [31,40]. We cannot
exclude the fact that the low-fat diet followed in our control group may have masked the potential
benefit of the MedDiet.
The present study has some limitations and strengths that should be considered. The first
limitation is the type of population participating in the study. As the participants were individuals
with either type 2 diabetes or several CVD risk factors, like obesity and smoking, our findings cannot
be extrapolated to younger subjects or to other populations. Moreover, these factors lead to the
production of proinflammatory and oxidative agents and might play important roles in accelerating
cataract formation. Furthermore, having type 2 diabetes could influence the strategy of when to
operate a cataract, because in these patients, earlier cataract extraction has been known to contribute to
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an improved visual outcome [41]. Second, the timing of cataract extraction depends on multiple factors
that can speed up or delay the surgery, including the ophthalmologist’s subjective decision; the patient’s
visual acuity, comorbidities, and patient waiting attitude; being a more objective outcome formation
of cataract diagnosed by slit lamp examination. Third, to assess the incidence of cataract surgery we
considered only one surgery event in every patient, even though the same patient underwent cataract
surgery in both eyes. This could have led to the underestimation of the real incidence of cataract
surgery in our cohort, because other similar trials have observed an incidence of cataract surgery
between 17.7% and 26.8% [42,43] , which was very different from our findings. Fourth, previous studies
have shown that a high total dietary fat intake is related to a greater risk of developing cataracts [40],
because dietary fat may affect lens cell membrane composition and function, which are related to
age-related cataract [44]. Although there is lack of evidence, a low-fat diet could have a preventive role
on the risk of cataract extraction. In our study, this diet could have masked the potential beneficial effect
of the MedDiet on the incidence of cataract surgery, because a low-fat diet (control group) could be as
effective as the MedDiet (intervention groups) in reducing the incidence of cataract surgery, without
showing any difference between the two groups. Fifth, considering the outcome we investigated in
this study, it could have been useful the additional presence of a fourth group (second control group)
following no specific diet (neither MedDiet nor low-fat diet) to compare it with the three groups of the
study to obtain information that could have indicated whether the MedDiet or the low-fat diet had any
correlation with the incidence of cataract surgery, as comparing only the study groups we could not
find any correlation. Sixth, the assessment of cataract surgery was not the primary endpoint, because
the PREDIMED trial was designed to assess the effect of the MedDiet on primary CVD prevention.
Lastly, our implicit assumption regarding the induction period for relating the diet to cataract surgery
could be regarded as insufficient, even if the induction period was 6–7 years in our study. Given that
cataract surgery implies there was a long-standing previous pathophysiological process in the lens,
which probably started many years before our recorded date of surgery, our assumption regarding the
induction period could provide an alternative explanation to our null results. We admit that we may
have reduced our sensitivity in identifying the cataract-related endpoint. However, the advantage of
using surgery in our operational definition of this endpoint is its high specificity. Moreover, it is well
known in epidemiology that, theoretically, with perfect specificity, the nondifferential sensitivity of
disease misclassification will not bias the relative risk estimate [45].
The main strengths of our study are its randomized design; long follow-up period relative
to previous studies; large sample size; good compliance with the dietary regimens assigned,
which is further supported by the MedDiet questionnaire results and changes in the biomarkers
of food supplementation; and the control for several potential confounders, which together with the
randomization allows us to rule out residual confounding.
5. Conclusions
In summary, the results of our analysis do not support that a MedDiet supplemented with EVOO
or nuts may reduce the incidence of cataract surgery when compared to a low-fat diet in a population
at a high risk of CVD. However, the present results should be interpreted with caution because the
absence of evidence does not indicate the lack of evidence of an effect. Further studies on a healthy
population, taking into account alternative definitions of the outcome, are needed to investigate the
association between the MedDiet and age-related cataract and to determine whether the MedDiet
could have a potential preventive role in cataract.
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